Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

DOCR reports steep reductions in hepatitis C cases after treatment regimen change; requests $1.3 million for next biennium

2639442 · March 14, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

DOCR medical staff told the appropriations committee the department will have treated the in‑custody hepatitis C caseload by mid‑biennium using an 8‑week regimen supported by new protocols and state lab partnerships; the department requested $1.3 million to treat incoming cases next biennium and described expanded STD screening initiatives.

Agency medical officials told the Appropriations — Human Resources Section on Thursday that DOCR’s hepatitis C treatment program has produced large reductions in prevalence among people entering custody and described continued funding needs.

Jessica Wilkins, DOCR chief nursing officer, said the department expects to have treated about 241 hepatitis C patients by February 2025 and projected the number treated to reach about 297 by the end of the biennium. Wilkins said DOCR adopted an 8‑week antiviral regimen after identifying an evidence base (identified by DOCR clinical staff and Dr.…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans